Maria Manley, LLM, a life sciences expert and London-based partner with Sidley Austin, provides a deep-dive look at the complexities of Brexit and how it is likely to challenge the biologics industry.

The parents of a six year old girl from Suffolk, with severe epilepsy, have run out of her medication, because of Brexit.

Firms face “crippling uncertainly” and there is a “real threat “of food and medicine shortages in the new year, Ian Blackford has said. / The SNP Westminster leader called for an economic impact assessment to be released on the costs of the PM's “extreme Tory Brexit plans”.

Inquiry hears of massive extra costs, a mountain of red tape, shrinking investment and chemicals ‘disappearing’ from UK market.

This video from January is US Pharma industry lobby telling US trade negotiators that US-UK trade deal is “an important opportunity” to deal with “artificially depressed prices” in UK - “dictated” via our “primary payer” system

Tahir Amin is a British lawyer based in America who is an expert on drug pricing and on previous trade negotiations.

Dr Philippa Whitford, MP and eminent breast cancer surgeon, shares her concerns for the future of our NHS following Brexit. Recorded in front of a live audience at Arran High School Theatre on Friday 13th September 2019.

England's Chief Medical Officer has told LBC she is concerned that a no-deal Brexit could mean the NHS cannot get the medicine it needs to save lives.

It comes after serious warning about food supply from supermarkets.

Police fear the fallout from a "no-deal" Brexit could lead to "wide-scale disruption and dangers for the general public" and have warned they may not have the resources to cope.

The European Medicines Agency or EMA ensures that the medicines in the European Union are effective and safe. Find out what EMA is in a nutshell and how it protects patients.